340 related articles for article (PubMed ID: 23028720)
1. Met receptor acts uniquely for survival and morphogenesis of EGFR-dependent normal mammary epithelial and cancer cells.
Accornero P; Miretti S; Bersani F; Quaglino E; Martignani E; Baratta M
PLoS One; 2012; 7(9):e44982. PubMed ID: 23028720
[TBL] [Abstract][Full Text] [Related]
2. Epidermal growth factor and hepatocyte growth factor cooperate to enhance cell proliferation, scatter, and invasion in murine mammary epithelial cells.
Accornero P; Miretti S; Starvaggi Cucuzza L; Martignani E; Baratta M
J Mol Endocrinol; 2010 Feb; 44(2):115-25. PubMed ID: 19850646
[TBL] [Abstract][Full Text] [Related]
3. Epidermal growth factor and hepatocyte growth factor receptors collaborate to induce multiple biological responses in bovine mammary epithelial cells.
Accornero P; Martignani E; Miretti S; Starvaggi Cucuzza L; Baratta M
J Dairy Sci; 2009 Aug; 92(8):3667-75. PubMed ID: 19620648
[TBL] [Abstract][Full Text] [Related]
4. Epidermal growth factor receptor plays a significant role in hepatocyte growth factor mediated biological responses in mammary epithelial cells.
Bonine-Summers AR; Aakre ME; Brown KA; Arteaga CL; Pietenpol JA; Moses HL; Cheng N
Cancer Biol Ther; 2007 Apr; 6(4):561-70. PubMed ID: 17495520
[TBL] [Abstract][Full Text] [Related]
5. Hepatocyte growth factor exerts multiple biological functions on bovine mammary epithelial cells.
Accornero P; Martignani E; Macchi E; Baratta M
J Dairy Sci; 2007 Sep; 90(9):4289-96. PubMed ID: 17699048
[TBL] [Abstract][Full Text] [Related]
6. SPRY1 regulates mammary epithelial morphogenesis by modulating EGFR-dependent stromal paracrine signaling and ECM remodeling.
Koledova Z; Zhang X; Streuli C; Clarke RB; Klein OD; Werb Z; Lu P
Proc Natl Acad Sci U S A; 2016 Sep; 113(39):E5731-40. PubMed ID: 27621461
[TBL] [Abstract][Full Text] [Related]
7. Fibroblast-secreted hepatocyte growth factor mediates epidermal growth factor receptor tyrosine kinase inhibitor resistance in triple-negative breast cancers through paracrine activation of Met.
Mueller KL; Madden JM; Zoratti GL; Kuperwasser C; List K; Boerner JL
Breast Cancer Res; 2012 Jul; 14(4):R104. PubMed ID: 22788954
[TBL] [Abstract][Full Text] [Related]
8. EGFR is dispensable for c-Met-mediated proliferation and survival activities in mouse adult liver oval cells.
Martínez-Palacián A; Del Castillo G; Herrera B; Fernández M; Roncero C; Fabregat I; Sánchez A
Cell Signal; 2012 Feb; 24(2):505-513. PubMed ID: 22001397
[TBL] [Abstract][Full Text] [Related]
9. Cross talk between c-Met and epidermal growth factor receptor during retinal pigment epithelial wound healing.
Xu KP; Yu FS
Invest Ophthalmol Vis Sci; 2007 May; 48(5):2242-8. PubMed ID: 17460286
[TBL] [Abstract][Full Text] [Related]
10. Reconstitution of mammary gland development in vitro: requirement of c-met and c-erbB2 signaling for branching and alveolar morphogenesis.
Niemann C; Brinkmann V; Spitzer E; Hartmann G; Sachs M; Naundorf H; Birchmeier W
J Cell Biol; 1998 Oct; 143(2):533-45. PubMed ID: 9786961
[TBL] [Abstract][Full Text] [Related]
11. Cooperative effect of hepatocyte growth factor and fibronectin in anchorage-independent survival of mammary carcinoma cells: requirement for phosphatidylinositol 3-kinase activity.
Qiao H; Saulnier R; Patryzkat A; Rahimi N; Raptis L; Rossiter J; Tremblay E; Elliott B
Cell Growth Differ; 2000 Feb; 11(2):123-33. PubMed ID: 10714768
[TBL] [Abstract][Full Text] [Related]
12. Functional EpoR pathway utilization is not detected in primary tumor cells isolated from human breast, non-small cell lung, colorectal, and ovarian tumor tissues.
Patterson SD; Rossi JM; Paweletz KL; Fitzpatrick VD; Begley CG; Busse L; Elliott S; McCaffery I
PLoS One; 2015; 10(3):e0122149. PubMed ID: 25807104
[TBL] [Abstract][Full Text] [Related]
13. External and internal EGFR-activating signals drive mammary epithelial cells proliferation and viability.
Morato A; Martignani E; Miretti S; Baratta M; Accornero P
Mol Cell Endocrinol; 2021 Jan; 520():111081. PubMed ID: 33181234
[TBL] [Abstract][Full Text] [Related]
14. MET activation mediates resistance to lapatinib inhibition of HER2-amplified gastric cancer cells.
Chen CT; Kim H; Liska D; Gao S; Christensen JG; Weiser MR
Mol Cancer Ther; 2012 Mar; 11(3):660-9. PubMed ID: 22238368
[TBL] [Abstract][Full Text] [Related]
15. Protein tyrosine kinase Syk modulates EGFR signalling in human mammary epithelial cells.
Ruschel A; Ullrich A
Cell Signal; 2004 Nov; 16(11):1249-61. PubMed ID: 15337524
[TBL] [Abstract][Full Text] [Related]
16. The hepatocyte growth factor isoform NK2 activates motogenesis and survival but not proliferation due to lack of Akt activation.
Mungunsukh O; Lee YH; Bottaro DP; Day RM
Cell Signal; 2016 Aug; 28(8):1114-23. PubMed ID: 27224506
[TBL] [Abstract][Full Text] [Related]
17. ErbB2 requires integrin alpha5 for anoikis resistance via Src regulation of receptor activity in human mammary epithelial cells.
Haenssen KK; Caldwell SA; Shahriari KS; Jackson SR; Whelan KA; Klein-Szanto AJ; Reginato MJ
J Cell Sci; 2010 Apr; 123(Pt 8):1373-82. PubMed ID: 20332114
[TBL] [Abstract][Full Text] [Related]
18. Epidermal growth factor receptor, c-erbB2 and c-erbB3 receptor interaction, and related cell cycle kinetics of SK-BR-3 and BT474 breast carcinoma cells.
Brockhoff G; Heiss P; Schlegel J; Hofstaedter F; Knuechel R
Cytometry; 2001 Aug; 44(4):338-48. PubMed ID: 11500850
[TBL] [Abstract][Full Text] [Related]
19. Oncogenic AKT1(E17K) mutation induces mammary hyperplasia but prevents HER2-driven tumorigenesis.
Mancini ML; Lien EC; Toker A
Oncotarget; 2016 Apr; 7(14):17301-13. PubMed ID: 27004402
[TBL] [Abstract][Full Text] [Related]
20. Met and c-Src cooperate to compensate for loss of epidermal growth factor receptor kinase activity in breast cancer cells.
Mueller KL; Hunter LA; Ethier SP; Boerner JL
Cancer Res; 2008 May; 68(9):3314-22. PubMed ID: 18451158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
